Hecht, M. F., Minguez, M., Aguirre, A., Fajardo, M., & Williams, O. (2025). The feasibility of the Community health worker Outreach and Navigation Network for Enhancing representation in Clinical Trials (CONNECT) model: A community-physician engagement approach for increasing representation in clinical trials. Contemporary Clinical Trials Communications, 46, 101521. https://doi.org/10.1016/j.conctc.2025.101521

Oas, H., Cook, L., Schwantes-An, T.-H., Walsh, L. E., Wills, A.-M., Mata, I. F., Nance, M. A., Beck, J. C., Naito, A., Marder, K., Alcalay, R. N., & Verbrugge, J. (2024). Participant-reported personal utility of genetic testing for Parkinson’s disease and interest in clinical trial participation. Npj Parkinson’s Disease, 10(1). https://doi.org/10.1038/s41531-024-00805-z

Mrugala, M. M., Shi, W., Iwomoto, F., Lukas, R. V., Palmer, J. D., Suh, J. H., & Glas, M. (2024). Global post‑marketing safety surveillance of Tumor Treating Fields (TTFields) therapy in over 25,000 patients with CNS malignancies treated between 2011–2022. Journal of Neuro-Oncology, 169(1), 25–38. https://doi.org/10.1007/s11060-024-04682-7

Inzerillo, S., Schwartz, N., Khalili, L., April Fu, W. Y., Tang, W., Pardilla, L. G.-, Gartshteyn, Y., Schmidt, N., Izmirly, P., & Askanase, A. (2024). 104 Demographic and clinical factors that contribute to clinical study enrollment in systemic lupus erythematosus. Achieving Equity in Lupus Care & Outcomes. https://doi.org/10.1136/lupus-2023-lupus21century.4

Nohria, A., Desai, D., Klein, E. J., Senna, M. M., Aguh, C., Farah, R. S., Bordone, L., Krueger, L. D., Mesinkovska, N., Cummins, D., & Lo Sicco, K. I. (2024). The overturn of Roe v Wade: Google searches for teratogenic medications following the U.S. Supreme Court ruling. International Journal of Women’s Dermatology, 10(2), e139. https://doi.org/10.1097/jw9.0000000000000139

Dioun, S., Perez, L., Sharaf, R., Hou, J., Wright, J. D., Prabhu, M., & Frey, M. (2024). 428 Cost-effectiveness of BRCA1 testing at time of obstetrical prenatal carrier screening for cancer prevention. American Journal of Obstetrics and Gynecology, 230(1), S236–S237. https://doi.org/10.1016/j.ajog.2023.11.454

Idnay, B., Fang, Y., Butler, A., Moran, J., Li, Z., Lee, J., Ta, C., Liu, C., Yuan, C., Chen, H., Stanley, E., Hripcsak, G., Larson, E., Marder, K., Chung, W., Ruotolo, B., & Weng, C. (2023). Uncovering key clinical trial features influencing recruitment. Journal of Clinical and Translational Science, 7(1). https://doi.org/10.1017/cts.2023.623

Jeon, E., Pappalardo, A., Sorrells, L., & Abaci, H. E. (2022). 707 Guiding skin organoid generation via extracellular matrix cues and spatially controlled morphogen gradients. Journal of Investigative Dermatology, 142(8), S122. https://doi.org/10.1016/j.jid.2022.05.719

Vena, N., Bogyo, K., Nestor, J., Sanna-Cherchi, S., Kiryluk, K., & Gharavi, A. (2022). eP270: Incorporating genetic services into adult kidney disease care. Genetics in Medicine, 24(3), S170–S171. https://doi.org/10.1016/j.gim.2022.01.305

Kahn, J. M., Gray, D. M., Oliveri, J. M., Washington, C. M., DeGraffinreid, C. R., & Paskett, E. D. (2021). Strategies to improve diversity, equity, and inclusion in clinical trials. Cancer, 128(2), 216–221. Portico. https://doi.org/10.1002/cncr.33905

Clayton, E. W., Appelbaum, P. S., Chung, W. K., Marchant, G. E., Roberts, J. L., & Evans, B. J. (2021). Does the law require reinterpretation and return of revised genomic results? Genetics in Medicine, 23(5), 833–836. https://doi.org/10.1038/s41436-020-01065-x